Artificial Intelligence and Predictive Models
This study aimed to develop an innovative modeling framework that seamlessly integrates physiologically-based pharmacokinetic (PBPK) principles with in vitro-in vivo correlation (IVIVC) methodology to predict human pharmacokinetics of sustained-release formulations, using ruxolitinib as a model compound.
Soyoung Shin, PhD (she/her/hers)
Associate Professor
Chung-Ang University
Seoul, Republic of Korea